Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
Drug Prices
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
Drug Prices
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Drug Prices
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Q&A
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
Drug Prices
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
President Biden Called on Congress to Lower Drug Prices. What’s Next?
Drug Prices
President Biden Called on Congress to Lower Drug Prices. What’s Next?
New Laws Take Aim at Drug Prices, But Stronger Action Needed
Drug Prices
New Laws Take Aim at Drug Prices, But Stronger Action Needed
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Prices
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Pricing Reform Enters a Big, New Battleground: States
Drug Prices
Drug Pricing Reform Enters a Big, New Battleground: States
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
Drug Prices
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
Drug Prices
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Drug Prices
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
'Evergreening' Stunts Competition, Costs Consumers and Taxpayers
Drug Prices
‘Evergreening’ Stunts Competition, Costs Consumers and Taxpayers
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
Drug Prices
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Drug Prices
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
Drug Prices
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
